韩国国际生物制药峰会2012是南韩唯一探讨生物制药,疫苗和生物仿制药产业和发展的独特平台。将于四月16-19日在首尔举行。此次会议将聚集韩国与国际顶尖生物制药企业的专家与学者,会着重于探讨如何促进生物制药产品和疫苗的开发与生产。今日韩国的生物和生物仿造药市场是亚洲发展最快和最有创新能力的市场之一,参会公司包括韩国三星,LG,绿十字等等制药集团和小型生物药物研发公司。不要错过这个难得的机会来和韩国的药企面对面,以及建立双边业务合作关系!
Speakers include:
B G Rhee, President, Green Cross, Korea
Tim Oldham, President, Asia Pacific, Hospira, Australia
Choi Chang Hoon, CEO, ISU Abxis, Korea
Yoo Jin San, President and CEO, PharmAbcine, Korea
Park Heung Rok, Director, ISU Abxis, China
Biologics World Korea 2012 brings you:
• The most targeted platform to meet Korean and international biologics manufacturers
• Case studies and discussions from senior level decision makers who will influence the direction of Korea's biologics industry
• Both strategic and technology-focused biologics development in Korea
Biologics World Korea 2012 Key topics include:
• Opportunities and challenges facing Korea Biologics Industry
• Innovation highlights: Biobetters and novel biologics development in Korea
• Innovation highlights: Vaccine Development in Korea
• Biomanufacturing upstream best practices
• Biomanufacturing downstream best practices
• Operational excellence and PAT
• Crystalballing the future of Korean industry
Contact person: Jasmine Wong
Email: jasmine.wong@imapac.com
Phone number: +65 6493 1598